Navigation Links
PCMA: CMS Releases Proposed E-Prescribing Standards in Medicare
Date:11/14/2007

E-Prescribing Will Improve Savings, Reduce Medication Errors

WASHINGTON, Nov. 14 /PRNewswire-USNewswire/-- The Pharmaceutical Care Management Association (PCMA) said today that the proposed standards for electronic prescribing (e-prescribing) released by the Centers for Medicare & Medicaid Services (CMS) confirm that the time is now to require e-prescribing in Medicare.

Following four years of extensive review by physicians, pharmacists, standard-setting organizations, and other stakeholders, CMS estimates tremendous savings and health benefits with increased adoption of e-prescribing. In the proposed standards, CMS estimates found that adoption of e-prescribing would:

-- Reduce Adverse Drug Events (ADEs);

-- Provide increased administrative savings to physicians, physician offices and pharmacists; and

-- Enhance generic utilization.

"CMS estimates even modest adoption of e-prescribing could save billions and greatly reduce adverse drug events (ADEs)," said PCMA President and CEO Mark Merritt.

The proposed e-prescribing standards were developed and pilot-tested during a rigorous process with consensus from a variety of influential health care stakeholders, including physicians; pharmacists; payers; the Department of Health and Human Services (HHS); the National Committee on Vital Health Statistics; and HIPAA-recognized standard setting organizations. In a positive note regarding interoperability, the proposed e-prescribing standards were created by the same organizations which developed Electronic Medical Records (EMR) standards. Requiring e-prescribing in Medicare is the first step toward broader adoption of overall health IT and would also serve as a model for the entire commercial market.

In the 2003 Medicare Modernization Act (MMA), Part D sponsors were required to accept e-prescribing and national standards were created for Medicare, however, physicians were not required to use the technology. As a result, fewer than one-in-ten physicians have chosen to use it. PCMA strongly believes the only realistic way to rapidly accelerate adoption of e-prescribing is to require physicians to use the technology in Medicare.

E-prescribing helps consumers avoid medication errors by providing physicians with real-time safety alerts when a new prescription would dangerously interact with others that have already been prescribed. Earlier this year, PCMA released a study from the Gorman Health Group showing that requiring e-prescribing in Medicare could prevent up to 1.9 million medication errors over the next decade and save billions -- even after providing funds for equipment and training.

PCMA last week launched a TV and print advertising campaign featuring J. Lyle Bootman, Ph.D., Sc.D., who last year co-chaired an Institute of Medicine (IOM) committee that recommended that all physicians begin using e-prescribing by 2010. In the TV ad, Dr. Bootman calls on policymakers to require e-prescribing in Medicare, "before more people die."

The new PCMA TV ad is available at http://www.pcmanet.org.

PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
2. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
3. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
4. Verdict One Releases Directory of Board Certified Attorneys for Consumers
5. Academy releases emergency preparedness tools to enable millions more people to shelter in place
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. MITEM Releases Blue Iris eLaborate 8.6
8. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
9. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
10. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
11. Cardiac Science Releases New Cardiac Rehabilitation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... September 25, 2017 , ... Ron ... an option to senior, upper-level executives speaking at a business luncheon today, "It ... high-level executive is an asset to be fully realized and activated by the ...
(Date:9/25/2017)... ... September 25, 2017 , ... “Renew Refresh Restore Reward”: is a ... Reward” is the creation of published author, Deborah Freeman, cofounded the Free Spirit Bible ... we returned to our cars, my sister-in-law invited us to come over before the ...
(Date:9/25/2017)... September 25, 2017 - Orlando, FL, Microsoft Ignite Conference (PRWEB) , ... ... ... Hosts, Inc . announced today that they have teamed up to deliver Netmail’s Hadron ... on-demand service from a HIPAA/HITRUST compliant Azure Cloud. Netmail will be demo-ing their Hadron ...
(Date:9/25/2017)... ... ... Ash Borers kill Ash trees in as little as 1-3 years. The signs ... by Rob Nagy, ISA Certified Arborist at Giroud Tree and Lawn, shows a street in ... signs of decline from Emerald Ash Borers, two Ash trees continue to thrive. ...
(Date:9/24/2017)... & Caicos Islands, BWI (PRWEB) , ... September 25, 2017 , ... ... to announce the resort is re-opening on October 1st. And, throughout the month ... three bedroom oceanfront rentals. , Hurricane Irma and Maria have passed and damage ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
Breaking Medicine Technology: